An Atypical Cutaneous Reaction to Rivastigmine Transdermal Patch
Joint Authors
Calvieri, Stefano
De Marco, I.
Rossi, M.
Pigatto, P.
Faina, V.
Grieco, T.
Source
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-2, 2 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-01-11
Country of Publication
Egypt
No. of Pages
2
Main Subjects
Abstract EN
Rivastigmine is a cholinesterase inhibitor which improves cognitive function and is currently being used in patients with mild to moderate Parkinson's and Alzheimer's dementia.
This drug can be given orally or topically, as transdermal patch.
The latter form is currently used for most excellent compliance and few side effects.
The most common cutaneous side effects are irritative dermatitis.
We report the second case of active sensitization by the rivastigmine-patch in a patient suffering from Alzheimer's dementia.
American Psychological Association (APA)
Grieco, T.& Rossi, M.& Faina, V.& De Marco, I.& Pigatto, P.& Calvieri, Stefano. 2011. An Atypical Cutaneous Reaction to Rivastigmine Transdermal Patch. Journal of Allergy،Vol. 2011, no. 2011, pp.1-2.
https://search.emarefa.net/detail/BIM-495919
Modern Language Association (MLA)
Grieco, T.…[et al.]. An Atypical Cutaneous Reaction to Rivastigmine Transdermal Patch. Journal of Allergy No. 2011 (2011), pp.1-2.
https://search.emarefa.net/detail/BIM-495919
American Medical Association (AMA)
Grieco, T.& Rossi, M.& Faina, V.& De Marco, I.& Pigatto, P.& Calvieri, Stefano. An Atypical Cutaneous Reaction to Rivastigmine Transdermal Patch. Journal of Allergy. 2011. Vol. 2011, no. 2011, pp.1-2.
https://search.emarefa.net/detail/BIM-495919
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-495919
